A 68-year-old woman with chronic atrial fibrillation on digoxin therapy presents with palpitations and dyspnea. Vital signs: HR 142 bpm (irregular), BP 98/62 mmHg, RR 24/min. ECG shows rapid atrial fibrillation with a ventricular rate of 140 bpm. Troponin and electrolytes are normal. Chest X-ray shows mild pulmonary edema. The patient is haemodynamically unstable. What is the most appropriate immediate next step?

Explanation

## Clinical Scenario Analysis This patient presents with **rapid atrial fibrillation (AF) with haemodynamic instability**, characterized by: - Rapid ventricular rate (142 bpm, irregular) - Hypotension (BP 98/62 mmHg) - Signs of pulmonary edema (dyspnea, CXR findings) - Haemodynamic compromise (symptomatic palpitations) ## Cardiac Output Regulation in Rapid AF **Key Point:** Cardiac output = Heart rate × Stroke volume. In rapid AF, both components are compromised: - **Elevated HR** (140 bpm) reduces diastolic filling time - **Loss of atrial kick** (no organized atrial contraction) reduces ventricular preload by ~20–30% - **Net result:** Severe reduction in stroke volume and cardiac output despite high heart rate **High-Yield:** Haemodynamic instability in rapid AF is due to loss of the atrial contribution to ventricular filling, not just tachycardia. This is why rate control alone may not restore stability if the rate remains very high. ## Management Algorithm for Rapid AF with Haemodynamic Instability ```mermaid flowchart TD A[Rapid AF with haemodynamic instability]:::outcome --> B{Haemodynamically unstable?}:::decision B -->|Yes| C[Synchronized DC cardioversion]:::action B -->|No| D[IV rate-control agents]:::action C --> E[Restore sinus rhythm & cardiac output]:::outcome D --> F[Achieve rate control 60-100 bpm]:::outcome G[Anticoagulation & long-term rhythm/rate control]:::action E --> G F --> G ``` ## Why DC Cardioversion Is the Answer 1. **Immediate restoration of sinus rhythm** → Restores atrial kick and diastolic filling 2. **Rapid improvement in cardiac output** → Addresses haemodynamic instability within seconds 3. **Guideline-mandated** — Synchronized DC cardioversion is the standard of care for haemodynamically unstable AF 4. **Urgency** — Hypotension + pulmonary edema = imminent cardiogenic shock; cannot wait for drug effect (which takes 15–30 min) **Clinical Pearl:** In haemodynamically unstable AF, "rate control" is a misnomer. The goal is **rhythm restoration** via cardioversion, not gradual rate reduction with drugs. ## Why Rate-Control Drugs Are Insufficient Here - **IV digoxin** — Slow onset (30–60 min), unreliable in acute AF, narrow therapeutic window - **IV beta-blockers (metoprolol)** — Onset 5–10 min, but may worsen hypotension - **IV calcium channel blockers (verapamil)** — Contraindicated in hypotension, negative inotropic effect - **Amiodarone** — Can be used but slower than cardioversion and has negative inotropic effects **Mnemonic: STABLE vs UNSTABLE AF** - **STABLE** (normal BP, no pulmonary edema) → IV rate control (digoxin, beta-blocker, CCB, amiodarone) - **UNSTABLE** (hypotension, pulmonary edema, altered mental status, chest pain) → **Synchronized DC cardioversion** ## Preoperative Considerations - **Sedation** — Use short-acting agents (propofol, etomidate) to maintain airway reflexes - **Anticoagulation** — Patient is on digoxin (chronic AF); assume thromboembolic risk. Cardioversion is safe if anticoagulated or if AF duration < 48 hours (or TEE excludes thrombus) - **Electrolytes** — Normal in this case; proceed with cardioversion **High-Yield:** Synchronized cardioversion (not defibrillation) is used for AF because the rhythm is organized; defibrillation is for VF/pulseless VT.